Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients

Fontein, D.B.Y.; Houtsma, D.; Hille, E.T.M.; Seynaeve, C.; Putter, H.; Kranenbarg, E.M.K.; ... ; Dutch TEAM Steering Comm (2012)

Article / Letter to editor

• adverse events
• aromatase inhibitors
• breast cancer
• estrogen receptors
• exemestane

• All authors: Fontein, D.B.Y.; Houtsma, D.; Hille, E.T.M.; Seynaeve, C.; Putter, H.; Kranenbarg, E.M.K.; Guchelaar, H.J.; Gelderblom, H.; Dirix, L.Y.; Paridaens, R.; Bartlett, J.M.S.; Nortier, J.W.R.; Velde, C.J.H. van de; Dutch TEAM Steering Comm
• Date: 2012-12-31
• Journal: Annals of Oncology
• Volume: 23
• Issue: 12
• Pages: 3091 - 3097
• DOI: doi:10.1093/annonc/mds204